NARISSA KOURINOS: Open Payments
NPI 1356018188 · BIDDEFORD, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,108 in 117 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $3,108
Food & beverage: $3,008Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $810 |
| Regeneron Healthcare Solutions, Inc. | 27 | $616 |
| GENZYME CORPORATION | 13 | $399 |
| Novartis Pharmaceuticals Corporation | 14 | $244 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $143 |
| CSL Behring | 5 | $138 |
| Amgen Inc. | 5 | $135 |
| GlaxoSmithKline, LLC. | 6 | $106 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Ionis Pharmaceuticals, Inc. | 3 | $74 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, NEFFY, Rhapsido, NUCALA, AYVAKIT, Haegarda.
Industry payments across ME — which companies pay providers there.
